Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data

Khatib, R; McKee, M; Shannon, H; Chow, C; Rangarajan, S; Teo, K; Wei, L; Mony, P; Mohan, V; Gupta, R; +23 more... Kumar, R; Vijayakumar, K; Lear, SA; Diaz, R; Avezum, A; Lopez-Jaramillo, P; Lanas, F; Yusoff, K; Ismail, N; Kazmi, K; Rahman, O; Rosengren, A; Monsef, N; Kelishadi, R; Kruger, A; Puoane, T; Szuba, A; Chifamba, J; Temizhan, A; Dagenais, G; Gafni, A; Yusuf, S; Investigators, PS; (2015) Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data. Lancet, 387 (10013). pp. 61-69. ISSN 0140-6736 DOI: https://doi.org/10.1016/s0140-6736(15)00469

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/s0140-6736(15)00469

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar